RESEARCHERS have been given pound(s)3 million funding to investigate how nanoparticles can be used to improve the diagnosis and treatment of cardiovascular disease.
The scientists based at Strathclyde University, working with colleagues at the Universities of Glasgow and Warwick, will aim to tackle the leading cause of mortality in the UK with the technology.
Principal Investigator Professor Duncan Graham, Director of the Centre for Molecular Nanometrology at the University of Strathclyde, said: "Cardiovascular diseases cause more than a quarter of all deaths in the UK each year, and death rates from coronary heart disease are highest in Scotland.
"Estimates suggest the UK spends nearly pound(s)2 billion each year on healthcare costs of treating coronary heart disease - our research combines nanotechnology with advanced statistical and biomedical research, focused on a clinical application which we hope will lead to a beneficial change in treatment of cardiovascular disease patients."
Dr Pasquale Maffia, senior lecturer in immunology at the University of Glasgow, said it could develop a "highly sensitive but relatively affordable" way of allowing a doctor to forecast the progression of the disease.